Skip to content

The effect of pelvic floor muscle training on bowel symptoms after low anterior resection for rectal cancer.

The effect of pelvic floor muscle training on bowel symptoms after low anterior resection for rectal cancer.

Status
Unknown
Phases
Phase 4
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON26845
Enrollment
Unknown
Registered
2017-01-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rectal cancer, bowel symptoms (fecal incontinence, urgency, frequency, fragmented defecation, soiling), Low Anterior Resection Syndrome Rectal cancer

Interventions

Bekkenbodemspiertraining

Sponsors

Research Foundation Flanders
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - patients planned for a low anterior resection for rectal cancer (TME, total mesorectal excision)  - patients who have an expected survival of at least 1.5 years - patients who are able to come to the hospital once a week during the complete treatment period (12 weeks) - patients with a minimal LARS score of 21/42

Exclusion criteria

Exclusion criteria: - having a HARTMANN procedure, abdominiperineal excision or transanal microsurgical resection or sigmoïd resection - patients with neurological conditions - patients with cognitive problems - patients with preoperative fecal incontinence - patients who have had precious pelvic surgery, previous pelvic radiation or LAR for non-cancer reasons  

Design outcomes

Primary

MeasureTime frame
LARS-score, evaluated after 12 weeks (=16 weeks after surgery/closure ileostomy) of pelvic floor muscle training

Secondary

MeasureTime frame
colorectal functional outcome questionnaire, bowel diaries, the evolution of physical activity after LAR for rectal cancer, colonic manometry in a subset of patients

Contacts

Public ContactInge Geraerts

Postbus 1501

inge.geraerts@faber.kuleuven.be+32 16329120

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)